An educational conference uniting cardiovascular, renal and metabolic care has strengthened its leadership team, reinforcing its commitment to delivering a new era of “smart healthcare”. 

Eleanor Cross Healthcare in Northampton has secured funding from the National Institute for Health and Care Research (NIHR) Capital Investment Programme to establish a dedicated primary care research clinic and laboratory supporting research into metabolic health, obesity and other long-term conditions.

Population-wide autoimmunity screening for type 1 diabetes across all age groups is feasible using minimally invasive capillary sampling and advanced immunoassay technology, latest research has claimed.

Diabetes Professional Care (DPC) has relaunched as Cardiovascular Renal Metabolic (CVRM) Professional Care, marking a national rebrand that brings key healthcare specialisms together to drive more integrated care and “improve patient outcomes.”

A high consumption of beef during childhood may contribute to type 1 diabetes development in genetically at-risk individuals, new evidence has revealed.

The LIM and SH3 protein 1 (LASP1) regulates the synthesis and activation of A Disintegrin and Metalloproteinase 17 (ADAM17) in mesangial cells and is required for the profibrotic response to high glucose.  

A UK health charity is calling on the public to help save the lives of mothers and children across Sub-Saharan Africa and is offering the chance to win luxury prizes in return.

Healthcare professionals are invited to learn about diabetic peripheral neuropathy and metabolic disorder during an online event next month.

Spirit Health is giving Diabetes Specialist Nurses (DSNs) and primary care teams the opportunity to reduce workload pressures and improve glucose management outcomes through a free, hands-on CareSens Air Continuous Glucose Monitor (CGM) experience, supported by structured nurse-led onboarding.

The Secretary of State for Health and Social Care has pledged to speak with a bereaved father whose two-year-old daughter died from undiagnosed type 1 diabetes last year.

Trend Diabetes is pleased to share an update on its committee membership, with a mix of returning members and new voices joining Debbie Hicks.

Following approval from its notified body, CamDiab Ltd announces its latest innovation that will allow users to manage their type 1 diabetes without needing to count carbohydrates or give pre-meal insulin.

Tailored training on diabetes technology is needed to improve diabetes care across community and primary care settings, latest research has revealed.

The Trustees of the Novo Nordisk UK Research Foundation (NNUKRF) and the Diabetes Care Trust are encouraging diabetes healthcare professionals to apply for a series of funding opportunities now open for applications.

Trend Diabetes has released a brand-new educational video “How to examine for lipohypertrophy,” delivered by Debbie Hicks, Chair of Trend Diabetes.

The Diabetes Africa UK Forum returns for its third year in 2025, continuing its mission to advance equity in diabetes care for Black populations.

People from Afro-Caribbean and South Asian backgrounds are less likely to be prescribed “life-changing” diabetes technology compared to White individuals, a new study has reported.

The first ever immunotherapy for type 1 diabetes has now been licensed for use in the UK.

A leading blood glucose testing company has launched a range of products with Well Pharmacy.